X

Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

New report shows more than 160 medicines in development for diabetes and related conditions

By Andrew Powaleny  |    April 24, 2019
Diabetes represents a significant public health issue in the U.S. It affects more than 30 million Americans, including around 7.2 million who are undiagnosed. Additionally, there are close to 1.5...   Read More

New report shows nearly 20 innovative medicines in development for sickle cell disease

By Andrew Powaleny  |    April 2, 2019
Sickle cell disease (SCD) is the most common inherited blood disorder in the United States, afflicting nearly 100,000 Americans. Patients with SCD have sickle-shaped red blood cells, which have...   Read More

130 medicines in development for asthma, allergies and other respiratory diseases

By Andrew Powaleny  |    February 21, 2019
Millions of Americans suffer from respiratory diseases, including Asthma and chronic obstructive pulmonary disease (COPD). Together, these two diseases affect the day-to-day lives of over 40...   Read More

New report shows nearly 300 cell and gene therapies in development

By Andrew Powaleny  |    December 6, 2018
Fifty years ago, the idea of altering a gene to treat or even cure a disease was considered science fiction. Today, cell and gene therapy are transforming treatment options for some patients and...   Read More

World AIDS Day 2018: Hope for the future

By Andrew Powaleny  |    December 1, 2018
Each year, I write to commemorate World AIDS Day which is now in its 30th year spotlighting patients living with HIV and those we’ve sadly lost to AIDS-related illnesses.   Read More

New report shows more than 300 skin disease medicines in development

By Andrew Powaleny  |    September 25, 2018
More than 100 million Americans – one third of the U.S. population – suffer from skin conditions.   Read More

New report details the setbacks and challenges to Alzheimer’s research

By Gretta Stone  |    September 12, 2018
Illustrating the challenges of developing medicines to fight Alzheimer’s disease, a new analysis found that between 1998 and 2017, there were 146 unsuccessful medicines in clinical trials for...   Read More

New report and resources put cancer in context, showing more than 1,100 medicines and vaccines in development

By Andrew Powaleny  |    May 30, 2018
In the not too distant past, chemotherapy and radiation were once the only treatments for what remains the second leading cause of death in the United States – cancer. Although the death rates of...   Read More

A new era in Alzheimer’s innovation

By Andrew Powaleny  |    April 19, 2018
After heart disease and cancer, Alzheimer’s disease and dementia are the leading cause of death for seniors, responsible for one out of every three deaths. Today, the disease devastates the minds...   Read More

New report shows over 500 medicines in development for neurological disorders

By Andrew Powaleny  |    April 18, 2018
Neurological disorders, which include more than 1,000 conditions that disrupt the brain and nervous system, affect an estimated 100 million Americans, nearly one third of the U.S. population....   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates